The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer

BACKGROUND: There is limited evidence relating to the cost-effectiveness of treatments for localised prostate cancer. METHODS: The cost-effectiveness of active monitoring, surgery, and radiotherapy was evaluated within the Prostate Testing for Cancer and Treatment (ProtecT) randomised controlled tri...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Br J Cancer
Main Authors: Noble, Sian M., Garfield, Kirsty, Lane, J. Athene, Metcalfe, Chris, Davis, Michael, Walsh, Eleanor I., Martin, Richard M., Turner, Emma L., Peters, Tim J., Thorn, Joanna C., Mason, Malcolm, Bollina, Prasad, Catto, James W. F., Doherty, Alan, Gnanapragasam, Vincent, Hughes, Owen, Kockelbergh, Roger, Kynaston, Howard, Paul, Alan, Paez, Edgar, Rosario, Derek J., Rowe, Edward, Oxley, Jon, Staffurth, John, Neal, David E., Hamdy, Freddie C., Donovan, Jenny L.
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7524753/
https://ncbi.nlm.nih.gov/pubmed/32669672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-0978-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares